ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Press
August 22, 2024
22 Aug 2024

Acarix AB (publ) publishes Interim Report, April – June 2024

Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its financial results for the second quarter of 20...
Continue reading
author-avatar
News
August 22, 2024
22 Aug 2024

Acarix AB (publ) publishes Interim Report, April – June 2024

Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its financial results for the second quarter of 20...
Continue reading
author-avatar acarix
Press
August 6, 2024
14 May 2024

Acarix AB (publ) publishes Interim Report, January – March 2024

Setting the stage for a strong 2024 and beyond One of the most notable achievements this quarter has been the successful implementation...
Continue reading
author-avatar acarix
Press
August 6, 2024
23 Apr 2024

Acarix AB’s Årsredovisning 2023

Acarix, ledande inom avancerad akustikbaserad hjärtdiagnostik, meddelar idag att årsredovisning för 2023 finns tillgänglig som pdf på b...
Continue reading
author-avatar acarix
Press
August 6, 2024
23 Apr 2024

Acarix AB’s Annual Report 2023

Acarix, a leader in advanced acoustic-based cardiac diagnostics, today announces that the Annual Report for 2023 is available as a pdf ...
Continue reading
author-avatar acarix
Press
August 6, 2024
15 Feb 2024

Acarix AB (publ) publicerar Bokslutskommuniké 2023

Fokus mot USA och hållbar tillväxt Som nyutnämnd VD är jag hedrad att få leda Acarix och dela en del av våra vision för framtiden. Foku...
Continue reading
author-avatar acarix
Press
August 6, 2024
15 Feb 2024

Acarix AB (publ) publishes Year-End Report 2023

Embarking on a new journey with focus on sustainable growth As the newly appointed CEO of Acarix, I am honored to be on board and share...
Continue reading
author-avatar acarix
Press
August 6, 2024
09 Nov 2023

Acarix AB (publ) publishes Interim Report, July – September 2023

Continued momentum in the US and strengthened financing in place We are pleased with the Q3 revenue growth in the US, where we are maki...
Continue reading
author-avatar acarix
Press
August 6, 2024
09 Nov 2023

Acarix AB (publ) publicerar delårsrapport, juli – september 2023

Fortsatt momentum i USA och stärkt finansiering på plats Vi är nöjda med intäktstillväxten i USA under Q3, där vi gör betydande investe...
Continue reading
author-avatar acarix
Press
August 6, 2024
31 Aug 2023

Acarix AB (publ) publishes Interim Report, April – June 2023

Traction in the US market reflects transition to a new expanded commercial model In 2022, we initiated the transition of Acarix to full...
Continue reading
author-avatar acarix
Press
August 6, 2024
31 Aug 2023

Acarix AB (publ) publicerar delårsrapport, april – juni 2023

Dragkraft på den amerikanska marknaden återspeglar övergången till en ny kommersiell modell Under 2022 påbörjades omställningen av Acar...
Continue reading
author-avatar acarix
Press
August 6, 2024
11 May 2023

Acarix AB (publ) publishes Interim Report, January – March 2023

2023 is off to a good start In the first quarter of 2023 our strategy delivered important results with a breakthrough order from the la...
Continue reading
  • 1
  • 2
  • 3
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
info@acarix.com

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.